Bosentan Tablet, For Suspension
NDC Package 70771-1908-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bosentan tablets is bosentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This formulation utilizes a tablet, for suspension delivery system. Marketed by Zydus Lifesciences Limited, this product is identified by NDC 70771-1908 and is authorized under FDA application ANDA213981.

Identification & Billing

NDC Package Code
70771-1908-8
Package Description
4 BLISTER PACK in 1 CARTON / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70771-1908-7)
Product Code
70771-1908
11-Digit Billing Format
70771190808
RxNorm Crosswalk
RxCUI: 1989081 - bosentan 32 MG Tablet for Oral Suspension

Clinical Specifications

Proprietary Name
Bosentan
Non-Proprietary Name
Bosentan
Substance Name
Bosentan
Dosage Form
Tablet, For Suspension - A tablet that forms a suspension when placed in a liquid (formerly referred to as a ‘dispersible tablet’).
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BOSENTAN 32 mg/1
Pharmacologic Class
Usage Information
Bosentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms from the disease, and improve your ability to exercise.

Regulatory & Marketing

Labeler Name
Zydus Lifesciences Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA213981
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-17-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70771-1908-8 identifies a specific commercial package of 4 blister pack in 1 carton / 14 tablet, for suspension in 1 blister pack (70771-1908-7) of Bosentan, a human prescription drug labeled by Zydus Lifesciences Limited. This tablet, for suspension is formulated for oral use and contains bosentan as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Lifesciences Limited on February 17, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Bosentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms from the disease, and improve your ability to exercise.

How is this Zydus Lifesciences Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70771190808. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70771-1908-8
11-Digit CMS (5-4-2)
70771-1908-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.